Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-11
2009-08-11
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S264110, C544S279000, C546S316000
Reexamination Certificate
active
07572801
ABSTRACT:
The invention is concerned with novel pyridopyrimidinone derivatives of formula (I):wherein R1to R8, X, Y, m and n are as defined in the description and in the claims. The compounds of the present invention are HM74A agonists with improved properties compared to niacin and can be used for the treatment and/or prevention of diseases such as dyslipidemia, atherosclerosis, diabetes, metabolic syndrome, and other related diseases associated with HM74A.
REFERENCES:
patent: 3950160 (1976-04-01), Abu El-Haj et al.
patent: WO 03/063874 (2003-08-01), None
patent: WO 2005105760 (2005-04-01), None
patent: WO 2005/077950 (2005-08-01), None
Jin et al. Arterioscler. Thromb. Vasc. Biol., 17, pp. 2020-2028 (1997).
Carlson et al., J. Intern. Med., 226, pp. 271-276 (1989).
Grundy et al., Arch. Intern. Med., 162, pp. 1568-1576 (2002).
Wise et al., J. Biol. Chem., 278 (11), pp. 9869-9874 (2003).
Soga et al., Biochem. Biophys. Res. Commun., 303, pp. 364-369 (2003).
Tunaru et al., Nature Medicine, 9, pp. 352-355 (2003).
Abarca et al., Tetrahedron, 45, pp. 7041-7048 (1989).
Sanmartin et al., Bioorg. Med. Chem., 13, pp. 2031-2044 (2005).
Taylor et al., J. Org. Chem., 19(10), pp. 1633-1640 (1954).
Robins et al., J. Am. Chem. Soc., 80, pp. 3449-3457 (1958).
Conte Aurelia
Dehmlow Henrietta
Grether Uwe
Kratochwil Nicole A.
Kuehne Holger
Berch Mark L
Hoffmann-La Roche Inc.
Jaisle Cecilia M
Johnston George W.
Remy Brian C.
LandOfFree
Pyridopyrimidinone derivatives which are HM74A agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridopyrimidinone derivatives which are HM74A agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridopyrimidinone derivatives which are HM74A agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4054903